Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma

Oncotarget
Milica StefanovicA Morales

Abstract

Evasive mechanisms triggered by the tyrosine kinase inhibitor sorafenib reduce its efficacy in hepatocellular carcinoma (HCC) treatment. Drug-resistant cancer cells frequently exhibit sphingolipid dysregulation, reducing chemotherapeutic cytotoxicity via the induction of ceramide-degrading enzymes. However, the role of ceramide in sorafenib therapy and resistance in HCC has not been clearly established. Our data reveals that ceramide-modifying enzymes, particularly glucosylceramide synthase (GCS), are upregulated during sorafenib treatment in hepatoma cells (HepG2 and Hep3B), and more importantly, in sorafenib-resistant cell lines. GCS silencing or pharmacological GCS inhibition sensitized hepatoma cells to sorafenib exposure. GCS inhibition, combined with sorafenib, triggered cytochrome c release and ATP depletion in sorafenib-treated hepatoma cells, leading to mitochondrial cell death after energetic collapse. Conversely, genetic GCS overexpression increased sorafenib resistance. Of interest, GCS inhibition improved sorafenib effectiveness in a xenograft mouse model, recovering drug sensitivity of sorafenib-resistant tumors in mice. In conclusion, our results reveal GCS induction as a mechanism of sorafenib resistance, sugges...Continue Reading

References

Mar 10, 2001·Journal of the National Cancer Institute·A SenchenkovM C Cabot
Sep 24, 2005·Cell·Sophie PattingreBeth Levine
Aug 31, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Laura LlacunaAlbert Morales
Sep 5, 2006·Cell Metabolism·Montserrat MaríCarmen García-Ruiz
Apr 14, 2007·Mini Reviews in Medicinal Chemistry·Albert Morales, José C Fernandez-Checa
Jan 25, 2008·Nature Reviews. Molecular Cell Biology·Yusuf A Hannun, Lina M Obeid
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Melissa A TranGavin P Robertson
Jul 3, 2008·Cancer Research·Joan MonteroJosé C Fernández-Checa
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
May 25, 2010·Developmental Cell·Stephen W G TaitDouglas R Green
Aug 28, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hayato HikitaNorio Hayashi
Jan 5, 2011·Gut·Hephzibah Rani S TagaramKevin F Staveley-O'Carroll
Jun 23, 2011·PloS One·Hyunmi LeeRichard Kolesnick
Jun 28, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wei-Ching HuangChiou-Feng Lin
Nov 3, 2011·Anti-cancer Agents in Medicinal Chemistry·Albert MoralesJose C Fernandez-Checa
Jan 25, 2012·Journal of Proteome Research·Vibeke Hervik BullBernd Thiede
Aug 28, 2012·Nature Chemical Biology·R David SentelleBesim Ogretmen
Dec 14, 2012·Nature Reviews. Cancer·Samy A F Morad, Myles C Cabot
Oct 2, 2013·Nature Reviews. Gastroenterology & Hepatology·Gregory A MichelottiAnna Mae Diehl
Jan 5, 2014·Biochimica Et Biophysica Acta·Jean-Philip TrumanYusuf A Hannun
Jan 8, 2014·Nature Reviews. Clinical Oncology·Augusto Villanueva, Josep M Llovet
Feb 5, 2014·Nature Reviews. Gastroenterology & Hepatology·Marcus-Alexander Wörns, Peter Robert Galle
Feb 6, 2014·Journal of Neurochemistry·Wei ShenWarren D Hirst
Mar 5, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Josep M Llovet, Virginia Hernandez-Gea
May 17, 2014·Journal of Cell Science·Stephen W G TaitDouglas R Green
Sep 23, 2014·Drugs·Raewyn M Poole

❮ Previous
Next ❯

Citations

Oct 27, 2017·Immunotherapy·S MolinoJ A Medin
Nov 18, 2017·Nature Reviews. Cancer·Besim Ogretmen
Jan 10, 2018·Oncotarget·Richard JennemannHermann-Josef Gröne
Apr 5, 2020·International Journal of Molecular Sciences·Katja JakobiGeorgios Grammatikos
Apr 6, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Josep M PiulatsAlberto Villanueva
Sep 20, 2020·Journal of Lipid Research·M Victoria SimonNawajes Mandal
Nov 5, 2020·Biomolecules·Naroa Insausti-UrkiaJose C Fernandez-Checa
Feb 15, 2020·Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids·Christa Buechler, Charalampos Aslanidis
Feb 9, 2021·Journal of Lipid Research·Simon M VictoriaMandal Nawajes
Sep 24, 2019·Current Medicinal Chemistry·Petra GrbčićMirela Sedić

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
xenograft
transfection
xenografts

Software Mentioned

ImageJ
GraphPad Prism

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.